Related references
Note: Only part of the references are listed.Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review
Nikki Agarwal et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2021)
Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description
Rodriguez Nunez Rosa Maria et al.
PLATELETS (2020)
Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
Rick Kapur et al.
PLATELETS (2020)
Management of immune thrombocytopenia in women: current standards and special considerations
Francesco Rodeghiero et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Use of romiplostim in pregnancy for refractory idiopathic thrombocytopenic purpura: Two case reports with maternal and fetal outcomes and literature review
Su J. Chua et al.
OBSTETRIC MEDICINE (2020)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert et al.
BLOOD ADVANCES (2019)
A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag
Naruko Suzuki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Refractory severe immune thrombocytopenia in a twin pregnancy
Patrick Harrington et al.
OBSTETRIC MEDICINE (2018)
Romiplostim: Successful treatment of a pregnant woman with refractory immune thrombocytopenia A case report and literature review
Mehrdad Payandeh et al.
BIOMEDICAL RESEARCH AND THERAPY (2018)
Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study
A. Care et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
Leila N. Varghese et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Clinical updates in adult immune thrombocytopenia
Michele P. Lambert et al.
BLOOD (2017)
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study
Francesco Zaja et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Matthieu Mahevas et al.
BLOOD (2016)
Current Management of Primary Immune Thrombocytopenia
Drew Provan et al.
ADVANCES IN THERAPY (2015)
Management of immune-mediated cytopenias in pregnancy
Caroline I. Piatek et al.
AUTOIMMUNITY REVIEWS (2015)
Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women
Valentine Loustau et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study
Henrik Frederiksen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Rescue Therapy With Romiplostim for Refractory Primary Immune Thrombocytopenia During Pregnancy
Justine Decroocq et al.
OBSTETRICS AND GYNECOLOGY (2014)
Use of a Thrombopoietin Mimetic for Chronic Immune Thrombocytopenic Purpura in Pregnancy
Avinash S. Patil et al.
OBSTETRICS AND GYNECOLOGY (2013)
Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus
J. K. Alkaabi et al.
LUPUS (2012)
Uterine NK Cells, Spiral Artery Modification and the Regulation of Blood Pressure During Mouse Pregnancy
Suzanne D. Burke et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2010)
Relationships between Hematopoiesis and Hepatogenesis in the Midtrimester Fetal Liver Characterized by Dynamic Transcriptomic and Proteomic Profiles
Yuanbiao Guo et al.
PLOS ONE (2009)
Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
Connie L. Erickson-Miller et al.
STEM CELLS (2009)
Long-term outcomes in adults with chronic ITP after splenectomy failure
R McMillan et al.
BLOOD (2004)
Share Paper
